Price Alert

Coloplast A/S (CLPBY)

OTC: CLPBY · Real-Time Price · USD

9.60

0.07 (0.72%)

At close: Jun 06, 2025, 3:58 PM

Coloplast A/S Balance Sheet Statement

Financials in DKK. Fiscal year is October - September.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
Cash & Equivalents	729M	906M	788M	887M	889M	916M	911M	855M	628M	671M	414M	634M	517M	642M	448M	447M	418M	435M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	-33M	-39M	-36M	16M	210M	219M	220M	220M	222M	226M	228M	257M	257M
Long-Term Investments	n/a	n/a	n/a	108M	111M	98M	104M	104M	52M	-159M	-168M	-177M	-179M	-181M	-185M	-203M	-232M	-232M
Other Long-Term Assets	121M	123M	102M	n/a	n/a	n/a	n/a	n/a	51M	240M	250M	249M	248M	248M	252M	259M	281M	280M
Receivables	5.49B	4.96B	5.04B	4.83B	4.64B	4.39B	4.32B	4.07B	3.99B	3.95B	3.94B	3.84B	3.65B	3.21B	3.21B	3.14B	3.11B	3.54B
Inventory	3.8B	3.67B	3.67B	3.68B	3.56B	3.52B	3.52B	3.56B	3.51B	3.4B	3.19B	3.02B	2.87B	2.5B	2.43B	2.38B	2.29B	2.23B
Other Current Assets	456M	420M	509M	885M	911M	849M	805M	821M	784M	649M	719M	776M	673M	527M	508M	467M	455M	629M
Total Current Assets	10.47B	10.37B	10.44B	10.64B	10.39B	10.07B	9.94B	9.67B	9.32B	9.28B	8.77B	8.7B	8.17B	7.28B	6.99B	6.83B	6.71B	6.64B
Property-Plant & Equipment	6.9B	6.75B	6.57B	6.43B	6.32B	6.07B	5.98B	5.79B	5.62B	5.4B	5.15B	4.92B	4.88B	4.42B	4.39B	4.23B	4.17B	4.04B
Goodwill & Intangibles	31.21B	30.64B	30.33B	30.57B	30.4B	31.44B	31.25B	18.86B	19.6B	19.8B	20.28B	20.64B	21.2B	3.68B	3.65B	3.63B	3.61B	3.52B
Total Long-Term Assets	38.69B	37.97B	37.63B	37.94B	37.75B	38.52B	38.22B	25.41B	25.98B	25.94B	26.18B	26.48B	27B	8.9B	8.85B	8.63B	8.54B	8.29B
Total Assets	49.15B	48.34B	48.07B	48.58B	48.14B	48.59B	48.16B	35.09B	35.3B	35.22B	34.96B	35.19B	35.17B	16.19B	15.84B	15.46B	15.25B	14.93B
Account Payables	1.21B	1.13B	1.52B	1.18B	1.23B	1.16B	1.29B	1.07B	1.14B	964M	1.24B	826M	755M	597M	1.04B	531M	572M	563M
Deferred Revenue	n/a	n/a	n/a	1.48B	1.33B	n/a	7.67B	3.71B	n/a	n/a	n/a	n/a	n/a	3.27B	2.93B	2.73B	2.58B	3.02B
Short-Term Debt	6.67B	7.2B	5.08B	6.96B	11.92B	9.19B	7.12B	4.83B	4.39B	4.96B	1.64B	3.51B	20.39B	4.43B	2.16B	3.68B	3.5B	4.02B
Other Current Liabilities	53M	57M	56M	2.58B	2.57B	8.33B	3.44B	2.2B	3.69B	4.34B	4.24B	4.08B	3.45B	-666M	2.93B	2.72B	2.57B	3.01B
Total Current Liabilities	10.97B	12.77B	10.2B	12.46B	17.3B	18.92B	16.31B	9.84B	9.43B	10.48B	7.34B	8.63B	24.81B	8.48B	6.31B	7.12B	6.82B	7.78B
Long-Term Debt	16.57B	16.56B	16.56B	11.56B	11.56B	11.55B	11.56B	16.39B	16.39B	16.36B	16.36B	16.37B	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	747M	500M	155M	2.28B	209M	213M	6M	8M	320M	340M	2.47B	191M	340M	3M	237M	341M	387M	264M
Total Long-Term Liabilities	21.24B	20.11B	19.93B	19.59B	14.63B	14.55B	14.55B	18.76B	18.84B	18.83B	19.33B	19.27B	3.09B	1.29B	1.36B	1.42B	1.49B	1.37B
Total Liabilities	32.21B	32.88B	30.13B	32.06B	31.94B	33.47B	30.86B	28.6B	28.27B	29.32B	26.66B	27.91B	27.9B	9.77B	7.67B	8.53B	8.31B	9.16B
Total Debt	24.26B	24.76B	22.63B	19.52B	24.51B	21.63B	19.57B	22.11B	21.65B	22.19B	18.71B	20.59B	21.08B	5.04B	2.79B	4.28B	4.13B	4.67B
Common Stock	228M	228M	228M	228M	228M	228M	228M	216M	216M	216M	216M	216M	216M	216M	216M	216M	216M	216M
Retained Earnings	16.29B	16.52B	15.39B	17.62B	17.45B	15.94B	14.63B	7.88B	6.57B	6.45B	5.39B	7.43B	6.18B	6.67B	5.41B	7.11B	6.08B	5.88B
Comprehensive Income	n/a	n/a	n/a	-1.32B	-1.48B	-1.04B	-1.16B	-1.6B	-816M	-762M	-495M	-370M	-187M	-465M	-433M	-400M	216M	-322M
Shareholders Equity	16.94B	15.46B	17.94B	16.52B	16.2B	15.13B	17.3B	6.49B	7.03B	5.91B	8.29B	7.28B	7.27B	6.42B	8.17B	6.93B	6.94B	5.77B
Total Investments	95M	95M	74M	108M	111M	65M	65M	68M	68M	51M	51M	43M	41M	41M	41M	25M	25M	25M